一般財団法人化学及血清療法研究所が製造販売する沈降精製百日せきジフテリア破傷風不活化ポリオ（セービン株）混合ワクチンについて｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000105418.htmlThe evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
一般財団法人化学及血清療法研究所が製造販売する沈降精製百日せきジフテリア破傷風不活化ポリオ（セービン株）混合ワクチンについて｜厚生労働省
Open the archived HTML with saved-time metadata attached.
This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.
This page announces the Ministry of Health, Labour and Welfare's decision regarding a quadrivalent vaccine "Quatrovac" manufactured by the Institute of Immunological Science. Following discovery of discrepancies between approved specifications and actual manufacturing practices, the ministry had requested a voluntary suspension of shipments in September. After detailed review, authorities determined no significant quality or safety issues existed. The Infectious Diseases Division of the Health Science Council recommended resuming shipments to prevent vaccine supply shortages. Consequently, the ministry lifted the shipment suspension on February 26, 2016.
